spacer
home > pmps > summer 2002 > the cphi worldwide 2002 conference preview - where science comes first
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The CPhI Worldwide 2002 Conference Preview - Where Science Comes First

This is where the CPhI conference comes in. The two-day programme will include high profile speakers presenting papers with in-depth scientific information on pharmaceutical techniques. The best way to measure the success of an exhibition such as CPhI Worldwide is to look at the actual number of attendees. Last year's combined event hosted 8,703 individual visitors, from over 110 countries around the world. Together with the exhibitors, the CPhI event in 2001 attracted almost 18,000 industry professionals.




France - A Major Market for Pharmaceuticals

'The French fine pharmaceutical chemicals industry is responsible for an annual turnover of US$3.7 billion and creates employment for over 20,000 people. Its 58 million residents - the second largest market in Europe and fourth largest in the world - are Europe's largest per capita consumers of pharmaceutical products. When calculated as a percentage of total health spending, France spends twice as much as the US does on medicine. Total turnover for pharmaceutical products amounted to US$20 billion in 1996 (approximately US$18 billion), about a quarter of which was exported.

The French pharmaceutical industry comprises 334 pharmaceutical companies in a very fragmented market. The top 20 companies in France controlled just 53 per cent of the domestic market in 1996. France ranked third after the US and Japan in a number of new pharmaceutical product launches in 1995. In 1996, France hosted the second highest number of biotech companies in Europe and, this year, hosts the third highest (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Rebecca Cavalôt of PMPS
spacer
Rebecca Cavalôt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement